tm logo
ARCUTIS
REGISTERED

on 16 Jul 2021

Last Applicant/ Owned by

ARCUTIS BIOTHERAPEUTICS INC.

3027 Townsgate Road, Suite 300Westlake Village, CA 91361

US

Serial Number

1903936 filed on 12th Jun 2018

Registration Number

TMA1103962 registered on 16th Jul 2021

Registration expiry Date

16th Jul 2031

Correspondent Address

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

ARCUTIS

Trademark usage description

house mark for a full line of pharmaceutical preparations namely pharmaceuticals for use in dermatology namely dermatitis, skin pigmentation, sexually Read More

Classification Information


Class [005]
House mark for a full line of pharmaceutical preparations namely pharmaceuticals for use in dermatology namely dermatitis, skin pigmentation, sexually transmitted diseases, eczema, psoriasis, skin cancer, acne, immunologic diseases and disorders namely auto immune diseases, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, virology namely human vaccines, oncology, for the treatment of hormonal conditions namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations, infertility, sexually transmitted diseases, incontinence and sexual dysfunction, dental diseases, for the treatment of bone disorders and spinal cord systems, neurological disorders namely brain injury, seizure disorders, stroke, Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, psychiatric namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, bipolar disorders, for ophthalmological use; pharmaceutical preparations for use in the diagnosis and treatment of dermatological diseases and disorders namely dermatitis, skin pigmentation, sexually transmitted diseases, eczema, psoriasis, skin cancer, acne, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, virology namely human vaccines, oncology, for the treatment of hormonal conditions namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations, infertility, sexually transmitted diseases, incontinence and sexual dysfunction, dental diseases, for the treatment of bone disorders and spinal cord systems, neurological disorders namely brain injury, seizure disorders, stroke, Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, psychiatric namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, bipolar disorders, for ophthalmological use, and diagnostic reagents for medical use


Classification kind code

11

Class [042]
Product research and development in the field of pharmaceuticals


Classification kind code

11

Mark Details


Serial Number

1903936

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 27
on 18th Mar 2021
Approval Notice Sent
Submitted for opposition 15
on 27th Jan 2021
Correspondence Created
Submitted for opposition 135
on 20th Jan 2021
Amendment to Application
Submitted for opposition 135
on 16th Sep 2020
Amendment to Application
Submitted for opposition 22
on 17th Jun 2020
Search Recorded
Submitted for opposition 20
on 17th Jun 2020
Examiner's First Report
Submitted for opposition 135
on 17th Apr 2019
Amendment to Application
Submitted for opposition 31
on 15th Jun 2018
Formalized
Submitted for opposition 1
on 13th Jun 2018
Created
Submitted for opposition 30
on 12th Jun 2018
Filed